Site Search

Share

X

Search Results

Legislation Introduced to Increase New Jerseyans’ Access to Biomarker Testing, the Key to Precision Medicine

Last week, legislation that seeks to improve New Jerseyans’ access to biomarker testing was introduced in the Legislature. Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. ...

Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing

... and cancer survivors from across New York will gather at the Capitol building on Wednesday, May 17 to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673, which aim to improve New Yorkers’ access to biomarker testing – a tool that opens the door to precision medicine.   WHAT:   Improving Access to Biomarker Testing: Opportunity to ...

Advocates to Urge State Lawmakers to Pass Biomarker Testing Bill at Annual Cancer Action Day

... Tennessee will travel to the state Capitol next Tuesday, February 11, to meet with lawmakers and ask for their support in ensuring coverage of biomarker testing. The bills ( HB0484 and SB0435 ) to ensure coverage were introduced on January 28. In the case of a cancer diagnosis, biomarker testing helps doctors determine the right therapy or treatment, saving some patients from more generalized treatments like chemo and ...

Governor Abbott Signs Legislation that Improves Access to Precision Testing for More Texans

... Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.     “ACS CAN thanks Sen. Joan Huffman and Rep. Greg Bonnen for ...

Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments

Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient.  The American Cancer Society Cancer Action Network (ACS CAN) and ... Cancer Centers. “Last year, I authored legislation to provide patients diagnosed with stages 3 and 4 cancer with prompt access to biomarker testing to inform their course of treatment. We know there are biomarker testing available for other conditions that can help healthcare ...

Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions

LUNGevity and ACS CAN partnered with Bruce Quinn Associates to develop materials to engage hospitals on pathologist-initiated biomarker testing, providing an overview of the MolDx clarification on CMS "treating physician" guidance. Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions ...

Lawmakers Rally with Patient Advocates to Improve Access to Biomarker Testing, Highlight Personal Connections to Disease

... leaders at the state Capitol and urged their colleagues in the House and Senate to support legislation improving Pennsylvanians’ access to biomarker testing. Biomarker testing has become a game-changing part of patient care given its role in opening the door to targeted treatments that can lead to ...

Nebraska Legislature Takes First Step in Improving Access to Biomarker Testing, But More Work Is Needed

... and provider groups in years to unite on a new health policy, we are glad to see that the Nebraska legislature recognizes the importance of biomarker testing and access to precision medicine for patients living with chronic disease.  We have concerns about the final bill language and will ... to ensure equitable access for all Nebraskans who can benefit.  The final bill language, which was signed by Gov. Pillen this week, limits biomarker testing coverage to an incomplete list of diseases and conditions. For example, current, proven applications in rare disease ...

Advocates Call for Senate Vote on Biomarker Testing Legislation, Citing Importance of Precision Medicine in Innovation

... lawmakers to support legislation that can improve access to clinical trials. Senate Bill 1196 / Assembly Bill 1673 seek to eliminate barriers to biomarker testing, which is increasingly critical to the participation in and development of clinical trials. Clinical trials are critical to medical ... potential new cancer treatments from the research setting to the cancer care clinic. Increasingly, cancer clinical trials are driven by biomarker testing and the development of targeted therapies. Patients’ biomarker testing results help to identify whether they might be eligible ...

Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support

... 17, 2023 – Earlier today, oncologists and cancer survivors from across New York gathered at the Capitol to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673. This legislation, which is being sponsored by Asm. Pamela Hunter and Sen. Roxanne Persaud and maintains bipartisan support, aims to improve New Yorkers’ access to precision medicine through biomarker testing. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy